You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

~ Buy the CALCIUM ACETATE Drug Excipient Business Development Opportunity Report, 2024 PDF Report in the Report Store ~

CALCIUM ACETATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Calcium Acetate, and what generic alternatives are available?

Calcium Acetate is a drug marketed by Amneal Pharms, Chartwell Rx, Heritage Pharms Inc, Hikma, Invagen Pharms, Lotus Pharm Co Ltd, Lupin Ltd, Nostrum Labs Inc, Square Pharms, Suven Pharms, Chartwell Molecular, and Padagis Us. and is included in fourteen NDAs.

The generic ingredient in CALCIUM ACETATE is calcium acetate. There are two hundred and eighty-two drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the calcium acetate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Calcium Acetate

A generic version of CALCIUM ACETATE was approved as calcium acetate by HIKMA on February 26th, 2008.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for CALCIUM ACETATE?
  • What are the global sales for CALCIUM ACETATE?
  • What is Average Wholesale Price for CALCIUM ACETATE?
Drug patent expirations by year for CALCIUM ACETATE
Drug Prices for CALCIUM ACETATE

See drug prices for CALCIUM ACETATE

Drug Sales Revenue Trends for CALCIUM ACETATE

See drug sales revenues for CALCIUM ACETATE

Recent Clinical Trials for CALCIUM ACETATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Peking University People's HospitalPhase 2
Mark FoxPhase 4
University of Colorado, DenverPhase 2

See all CALCIUM ACETATE clinical trials

Pharmacology for CALCIUM ACETATE
Paragraph IV (Patent) Challenges for CALCIUM ACETATE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
PHOSLYRA Oral Solution calcium acetate 667 mg/5 mL 022581 2 2013-12-05
PHOSLO GELCAPS Capsules calcium acetate EQ 169 mg calcium 021160 1 2005-05-31

US Patents and Regulatory Information for CALCIUM ACETATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal Pharms CALCIUM ACETATE calcium acetate CAPSULE;ORAL 201658-001 Oct 6, 2014 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Lupin Ltd CALCIUM ACETATE calcium acetate CAPSULE;ORAL 202127-001 Jul 9, 2015 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hikma CALCIUM ACETATE calcium acetate CAPSULE;ORAL 077728-001 Feb 26, 2008 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Heritage Pharms Inc CALCIUM ACETATE calcium acetate TABLET;ORAL 202885-001 Jan 22, 2015 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.